Skip to main content

Table 1 Distribution of nuclear and cytoplasmic YAP and TAZ positivity in human CCA subtypes

From: Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma

iCC (152) YAP TAZ YAP or TAZ YAP and TAZ
nuclear 60 (39.5%) 48 (31.6%) 66 (43.4%) 21 (13.8%)
cytoplasmic 43 (28.3%) 4 (2.6%) 43 (28.3%) 2 (1.3%)
nuc. and cytopl. 68 (44.7%) 49 (32.2%) 69 (45.4%) 24 (15.8%)
pCC (155) YAP TAZ YAP or TAZ YAP and TAZ
nuclear 65 (41.9%) 55 (35.5%) 50 (32.3%) 35 (22.6%)
cytoplasmic 48 (31%) 3 (1.9%) 49 (31.6%) 1 (0.6%)
nuc. and cytopl. 76 (49%) 57 (36.8%) 57 (36.8%) 38 (24.5%)
dCC (126) YAP TAZ YAP or TAZ YAP and TAZ
nuclear 37 (29.4%) 83 (65.9%) 62 (49.2%) 29 (23%)
cytoplasmic 39 (31%) 6 (4.8%) 43 (34.1%) 1 (0.8%)
nuc. and cytopl. 55 (43.7%) 84 (66.7%) 55 (43.7%) 42 (33.3%)